Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Nov. 30, 2015	Nov. 30, 2014	Nov. 30, 2013
Operating activities
Net income	$ 401.6	$ 437.9	$ 389.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	105.9	102.7	106.0
Stock-based compensation	18.7	18.2	18.7
Brand name impairment included in special charges	9.6	0.0	6.4
Special charges	22.8	5.2	18.6
Loss on voluntary pension settlement	0.0	0.0	15.3
Loss on sale of assets	0.6	1.3	0.3
Deferred income taxes	1.0	6.1	(15.3)
Income from unconsolidated operations	(36.7)	(29.4)	(23.2)
Changes in operating assets and liabilities:
Trade accounts receivable	15.6	(16.4)	(29.2)
Inventories	(18.0)	(54.4)	(59.9)
Trade accounts payable	40.4	(6.7)	12.1
Other assets and liabilities	(2.4)	23.3	21.8
Dividends received from unconsolidated affiliates	30.9	15.8	4.6
Net cash provided by operating activities	590.0	503.6	465.2
Investing activities
Acquisitions of businesses	(210.9)	0.0	(142.3)
Capital expenditures	(128.4)	(132.7)	(99.9)
Proceeds from sale of property, plant and equipment	0.4	1.1	2.5
Net cash used in investing activities	(338.9)	(131.6)	(239.7)
Financing activities
Short-term borrowings, net	(127.4)	57.7	71.9
Long-term debt borrowings	247.0	0.0	246.2
Long-term debt repayments	(1.6)	(1.6)	(251.4)
Proceeds from exercised stock options	33.1	31.7	44.7
Common stock acquired by purchase	(145.8)	(244.3)	(177.4)
Dividends paid	(204.9)	(192.4)	(179.9)
Net cash used in financing activities	(199.6)	(348.9)	(245.9)
Effect of exchange rate changes on cash and cash equivalents	(16.2)	(8.8)	4.4
Increase (decrease) in cash and cash equivalents	35.3	14.3	(16.0)
Cash and cash equivalents at beginning of year	77.3	63.0	79.0
Cash and cash equivalents at end of year	$ 112.6	$ 77.3	$ 63.0